BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2828 related articles for article (PubMed ID: 33323262)

  • 1. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
    Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
    Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the potential causal role of insomnia symptoms on 11,409 health-related outcomes: a phenome-wide Mendelian randomisation analysis in UK Biobank.
    Gibson MJ; Lawlor DA; Millard LAC
    BMC Med; 2023 Apr; 21(1):128. PubMed ID: 37013595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenome-wide investigation of the causal associations between childhood BMI and adult trait outcomes: a two-sample Mendelian randomization study.
    Dong SS; Zhang K; Guo Y; Ding JM; Rong Y; Feng JC; Yao S; Hao RH; Jiang F; Chen JB; Wu H; Chen XF; Yang TL
    Genome Med; 2021 Mar; 13(1):48. PubMed ID: 33771188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study.
    Lyall DM; Celis-Morales C; Ward J; Iliodromiti S; Anderson JJ; Gill JMR; Smith DJ; Ntuk UE; Mackay DF; Holmes MV; Sattar N; Pell JP
    JAMA Cardiol; 2017 Aug; 2(8):882-889. PubMed ID: 28678979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenome-wide Mendelian-randomization study of genetically determined vitamin D on multiple health outcomes using the UK Biobank study.
    Meng X; Li X; Timofeeva MN; He Y; Spiliopoulou A; Wei WQ; Gifford A; Wu H; Varley T; Joshi P; Denny JC; Farrington SM; Zgaga L; Dunlop MG; McKeigue P; Campbell H; Theodoratou E
    Int J Epidemiol; 2019 Oct; 48(5):1425-1434. PubMed ID: 31518429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lean mass, grip strength and risk of type 2 diabetes: a bi-directional Mendelian randomisation study.
    Yeung CHC; Au Yeung SL; Fong SSM; Schooling CM
    Diabetologia; 2019 May; 62(5):789-799. PubMed ID: 30798333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
    Leong A; Cole JB; Brenner LN; Meigs JB; Florez JC; Mercader JM
    PLoS Med; 2021 Mar; 18(3):e1003553. PubMed ID: 33661905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Causal Effects of Blood Iron and Copper on Lipid Metabolism Diseases: Evidence from Phenome-Wide Mendelian Randomization Study.
    Zhou J; Liu C; Francis M; Sun Y; Ryu MS; Grider A; Ye K
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33080795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for the causal effects of body mass index in over 300 000 participants in UK Biobank, using Mendelian randomization.
    Millard LAC; Davies NM; Tilling K; Gaunt TR; Davey Smith G
    PLoS Genet; 2019 Feb; 15(2):e1007951. PubMed ID: 30707692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of genetically predicted fatty acid levels across the phenome: A mendelian randomisation study.
    Zagkos L; Dib MJ; Pinto R; Gill D; Koskeridis F; Drenos F; Markozannes G; Elliott P; Zuber V; Tsilidis K; Dehghan A; Tzoulaki I
    PLoS Med; 2022 Dec; 19(12):e1004141. PubMed ID: 36580444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.
    Larsson SC; Bäck M; Rees JMB; Mason AM; Burgess S
    Eur Heart J; 2020 Jan; 41(2):221-226. PubMed ID: 31195408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically instrumented LDL-cholesterol lowering and multiple disease outcomes: A Mendelian randomization phenome-wide association study in the UK Biobank.
    Pham K; Mulugeta A; Lumsden A; Hyppӧnen E
    Br J Clin Pharmacol; 2023 Oct; 89(10):2992-3004. PubMed ID: 37208559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index and all-cause mortality in HUNT and UK biobank studies: revised non-linear Mendelian randomisation analyses.
    Burgess S; Sun YQ; Zhou A; Buck C; Mason AM; Mai XM
    BMJ Open; 2024 May; 14(5):e081399. PubMed ID: 38749693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study.
    Si S; Li J; Tewara MA; Xue F
    Front Immunol; 2021; 12():720876. PubMed ID: 34386016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood adiposity and novel subtypes of diabetes in adults: a Mendelian randomisation and genome-wide genetic correlation study.
    Wei Y; Zhan Y; Carlsson S
    Lancet Glob Health; 2023 Mar; 11 Suppl 1():S1. PubMed ID: 36866468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives.
    Richardson TG; Wang Q; Sanderson E; Mahajan A; McCarthy MI; Frayling TM; Ala-Korpela M; Sniderman A; Smith GD; Holmes MV
    Lancet Healthy Longev; 2021 Jun; 2(6):e317-e326. PubMed ID: 34729547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying potential causal effects of age at menarche: a Mendelian randomization phenome-wide association study.
    Magnus MC; Guyatt AL; Lawn RB; Wyss AB; Trajanoska K; Küpers LK; Rivadeneira F; Tobin MD; London SJ; Lawlor DA; Millard LAC; Fraser A
    BMC Med; 2020 Mar; 18(1):71. PubMed ID: 32200763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Potential Causal Effects of Telomere Length on Health Outcomes: A Phenome-Wide Investigation and Mendelian Randomization Study.
    Wang W; Huang N; Zhuang Z; Song Z; Li Y; Dong X; Xiao W; Zhao Y; Jia J; Liu Z; Qi L; Huang T
    J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37209418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses.
    Sun YQ; Burgess S; Staley JR; Wood AM; Bell S; Kaptoge SK; Guo Q; Bolton TR; Mason AM; Butterworth AS; Di Angelantonio E; Vie GÅ; Bjørngaard JH; Kinge JM; Chen Y; Mai XM
    BMJ; 2019 Mar; 364():l1042. PubMed ID: 30957776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 142.